# App-Assisted Day Reconstruction to Reduce Logistic Toxicity in Cancer

> **NCT05502302** · — · COMPLETED · sponsor: **Masonic Cancer Center, University of Minnesota** · enrollment: 23 (actual)

## Conditions studied

- Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05502302
- **Lead sponsor:** Masonic Cancer Center, University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-28
- **Primary completion:** 2023-02-28
- **Final completion:** 2023-02-28
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2024-07-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05502302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05502302, "App-Assisted Day Reconstruction to Reduce Logistic Toxicity in Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05502302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
